img

Global Gastrointestinal Cancer Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Gastrointestinal Cancer Treatment Market Insights, Forecast to 2034

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Market Analysis and InsightsGlobal Gastrointestinal Cancer Treatment Market
Global Gastrointestinal Cancer Treatment market is expected to reach to US$ 4536 million in 2023, with a positive growth of %, compared with US$ 4012 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Gastrointestinal Cancer Treatment industry is evaluated to reach US$ 9225.2 million in 2033. The CAGR will be 12.6% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Gastrointestinal Cancer Treatment market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Gastrointestinal Cancer Treatment market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Mylan N.V.
Samsung Bioepis
Teva Pharmaceutical Industries Ltd.
Segment by Type
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy

Segment by Application


Hospitals
Clinics
Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Gastrointestinal Cancer Treatment introduction, etc. Gastrointestinal Cancer Treatment Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Gastrointestinal Cancer Treatment
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Surgery
1.2.3 Targeted Drugs Therapy
1.2.4 Chemo Therapy
1.2.5 Adjuvant Chemotherapy
1.2.6 Radiation Therapy
1.3 Market by Application
1.3.1 Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Cancer Treatment Market Perspective (2018-2033)
2.2 Global Gastrointestinal Cancer Treatment Growth Trends by Region
2.2.1 Gastrointestinal Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gastrointestinal Cancer Treatment Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2024-2033)
2.3 Gastrointestinal Cancer Treatment Market Dynamics
2.3.1 Gastrointestinal Cancer Treatment Industry Trends
2.3.2 Gastrointestinal Cancer Treatment Market Drivers
2.3.3 Gastrointestinal Cancer Treatment Market Challenges
2.3.4 Gastrointestinal Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gastrointestinal Cancer Treatment by Players
3.1.1 Global Gastrointestinal Cancer Treatment Revenue by Players (2018-2023)
3.1.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gastrointestinal Cancer Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gastrointestinal Cancer Treatment Market Concentration Ratio
3.4.1 Global Gastrointestinal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Treatment Revenue in 2022
3.5 Global Key Players of Gastrointestinal Cancer Treatment Head office and Area Served
3.6 Global Key Players of Gastrointestinal Cancer Treatment, Product and Application
3.7 Global Key Players of Gastrointestinal Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Cancer Treatment Breakdown Data by Type
4.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2024-2033)
5 Gastrointestinal Cancer Treatment Breakdown Data by Application
5.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gastrointestinal Cancer Treatment Market Size (2018-2033)
6.2 North America Gastrointestinal Cancer Treatment Market Size by Type
6.2.1 North America Gastrointestinal Cancer Treatment Market Size by Type (2018-2023)
6.2.2 North America Gastrointestinal Cancer Treatment Market Size by Type (2024-2033)
6.2.3 North America Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
6.3 North America Gastrointestinal Cancer Treatment Market Size by Application
6.3.1 North America Gastrointestinal Cancer Treatment Market Size by Application (2018-2023)
6.3.2 North America Gastrointestinal Cancer Treatment Market Size by Application (2024-2033)
6.3.3 North America Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
6.4 North America Gastrointestinal Cancer Treatment Market Size by Country
6.4.1 North America Gastrointestinal Cancer Treatment Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023)
6.4.3 North America Gastrointestinal Cancer Treatment Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gastrointestinal Cancer Treatment Market Size (2018-2033)
7.2 Europe Gastrointestinal Cancer Treatment Market Size by Type
7.2.1 Europe Gastrointestinal Cancer Treatment Market Size by Type (2018-2023)
7.2.2 Europe Gastrointestinal Cancer Treatment Market Size by Type (2024-2033)
7.2.3 Europe Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
7.3 Europe Gastrointestinal Cancer Treatment Market Size by Application
7.3.1 Europe Gastrointestinal Cancer Treatment Market Size by Application (2018-2023)
7.3.2 Europe Gastrointestinal Cancer Treatment Market Size by Application (2024-2033)
7.3.3 Europe Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
7.4 Europe Gastrointestinal Cancer Treatment Market Size by Country
7.4.1 Europe Gastrointestinal Cancer Treatment Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Gastrointestinal Cancer Treatment Market Size by Country (2018-2023)
7.4.3 Europe Gastrointestinal Cancer Treatment Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gastrointestinal Cancer Treatment Market Size (2018-2033)
8.2 China Gastrointestinal Cancer Treatment Market Size by Type
8.2.1 China Gastrointestinal Cancer Treatment Market Size by Type (2018-2023)
8.2.2 China Gastrointestinal Cancer Treatment Market Size by Type (2024-2033)
8.2.3 China Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
8.3 China Gastrointestinal Cancer Treatment Market Size by Application
8.3.1 China Gastrointestinal Cancer Treatment Market Size by Application (2018-2023)
8.3.2 China Gastrointestinal Cancer Treatment Market Size by Application (2024-2033)
8.3.3 China Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Gastrointestinal Cancer Treatment Market Size (2018-2033)
9.2 Asia Gastrointestinal Cancer Treatment Market Size by Type
9.2.1 Asia Gastrointestinal Cancer Treatment Market Size by Type (2018-2023)
9.2.2 Asia Gastrointestinal Cancer Treatment Market Size by Type (2024-2033)
9.2.3 Asia Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
9.3 Asia Gastrointestinal Cancer Treatment Market Size by Application
9.3.1 Asia Gastrointestinal Cancer Treatment Market Size by Application (2018-2023)
9.3.2 Asia Gastrointestinal Cancer Treatment Market Size by Application (2024-2033)
9.3.3 Asia Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
9.4 Asia Gastrointestinal Cancer Treatment Market Size by Region
9.4.1 Asia Gastrointestinal Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Gastrointestinal Cancer Treatment Market Size by Region (2018-2023)
9.4.3 Asia Gastrointestinal Cancer Treatment Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Gastrointestinal Cancer Treatment Introduction
11.1.4 Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.1.5 Eli Lilly Recent Developments
11.2 F. Hoffmann
11.2.1 F. Hoffmann Company Details
11.2.2 F. Hoffmann Business Overview
11.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Introduction
11.2.4 F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.2.5 F. Hoffmann Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Gastrointestinal Cancer Treatment Introduction
11.4.4 Merck Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.4.5 Merck Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Gastrointestinal Cancer Treatment Introduction
11.5.4 Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.5.5 Novartis AG Recent Developments
11.6 Otsuka Holdings
11.6.1 Otsuka Holdings Company Details
11.6.2 Otsuka Holdings Business Overview
11.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Introduction
11.6.4 Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.6.5 Otsuka Holdings Recent Developments
11.7 Stryker Corporation
11.7.1 Stryker Corporation Company Details
11.7.2 Stryker Corporation Business Overview
11.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Introduction
11.7.4 Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.7.5 Stryker Corporation Recent Developments
11.8 Boston Scientific Corporation
11.8.1 Boston Scientific Corporation Company Details
11.8.2 Boston Scientific Corporation Business Overview
11.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Introduction
11.8.4 Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.8.5 Boston Scientific Corporation Recent Developments
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Company Details
11.9.2 Johnson and Johnson Business Overview
11.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Introduction
11.9.4 Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.9.5 Johnson and Johnson Recent Developments
11.10 CONMED Corporation
11.10.1 CONMED Corporation Company Details
11.10.2 CONMED Corporation Business Overview
11.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Introduction
11.10.4 CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.10.5 CONMED Corporation Recent Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.11.5 Bristol-Myers Squibb Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Gastrointestinal Cancer Treatment Introduction
11.12.4 Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.12.5 Pfizer Recent Developments
11.13 Celltrion Inc
11.13.1 Celltrion Inc Company Details
11.13.2 Celltrion Inc Business Overview
11.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Introduction
11.13.4 Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.13.5 Celltrion Inc Recent Developments
11.14 Amgen Limited
11.14.1 Amgen Limited Company Details
11.14.2 Amgen Limited Business Overview
11.14.3 Amgen Limited Gastrointestinal Cancer Treatment Introduction
11.14.4 Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.14.5 Amgen Limited Recent Developments
11.15 Celgene Corporation
11.15.1 Celgene Corporation Company Details
11.15.2 Celgene Corporation Business Overview
11.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Introduction
11.15.4 Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.15.5 Celgene Corporation Recent Developments
11.16 Sanofi
11.16.1 Sanofi Company Details
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Gastrointestinal Cancer Treatment Introduction
11.16.4 Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.16.5 Sanofi Recent Developments
11.17 Mylan N.V.
11.17.1 Mylan N.V. Company Details
11.17.2 Mylan N.V. Business Overview
11.17.3 Mylan N.V. Gastrointestinal Cancer Treatment Introduction
11.17.4 Mylan N.V. Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.17.5 Mylan N.V. Recent Developments
11.18 Samsung Bioepis
11.18.1 Samsung Bioepis Company Details
11.18.2 Samsung Bioepis Business Overview
11.18.3 Samsung Bioepis Gastrointestinal Cancer Treatment Introduction
11.18.4 Samsung Bioepis Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.18.5 Samsung Bioepis Recent Developments
11.19 Teva Pharmaceutical Industries Ltd.
11.19.1 Teva Pharmaceutical Industries Ltd. Company Details
11.19.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.19.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Introduction
11.19.4 Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Cancer Treatment Business (2018-2023)
11.19.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Surgery
Table 3. Key Players of Targeted Drugs Therapy
Table 4. Key Players of Chemo Therapy
Table 5. Key Players of Adjuvant Chemotherapy
Table 6. Key Players of Radiation Therapy
Table 7. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Gastrointestinal Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Gastrointestinal Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Gastrointestinal Cancer Treatment Market Share by Region (2018-2023)
Table 11. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Gastrointestinal Cancer Treatment Market Share by Region (2024-2033)
Table 13. Gastrointestinal Cancer Treatment Market Trends
Table 14. Gastrointestinal Cancer Treatment Market Drivers
Table 15. Gastrointestinal Cancer Treatment Market Challenges
Table 16. Gastrointestinal Cancer Treatment Market Restraints
Table 17. Global Gastrointestinal Cancer Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Gastrointestinal Cancer Treatment Revenue Share by Players (2018-2023)
Table 19. Global Top Gastrointestinal Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2022)
Table 20. Global Gastrointestinal Cancer Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Gastrointestinal Cancer Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Gastrointestinal Cancer Treatment, Headquarters and Area Served
Table 23. Global Key Players of Gastrointestinal Cancer Treatment, Product and Application
Table 24. Global Key Players of Gastrointestinal Cancer Treatment, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastrointestinal Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2024-2033)
Table 30. Global Gastrointestinal Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Gastrointestinal Cancer Treatment Revenue Share by Application (2018-2023)
Table 32. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Gastrointestinal Cancer Treatment Revenue Share by Application (2024-2033)
Table 34. North America Gastrointestinal Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Gastrointestinal Cancer Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Gastrointestinal Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Gastrointestinal Cancer Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Gastrointestinal Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Gastrointestinal Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Gastrointestinal Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Gastrointestinal Cancer Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Gastrointestinal Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Gastrointestinal Cancer Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Gastrointestinal Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Gastrointestinal Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Gastrointestinal Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Gastrointestinal Cancer Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Gastrointestinal Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Gastrointestinal Cancer Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Gastrointestinal Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Gastrointestinal Cancer Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Gastrointestinal Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Gastrointestinal Cancer Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Gastrointestinal Cancer Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Gastrointestinal Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Gastrointestinal Cancer Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 66. Eli Lilly Company Details
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Gastrointestinal Cancer Treatment Product
Table 69. Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 70. Eli Lilly Recent Developments
Table 71. F. Hoffmann Company Details
Table 72. F. Hoffmann Business Overview
Table 73. F. Hoffmann Gastrointestinal Cancer Treatment Product
Table 74. F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 75. F. Hoffmann Recent Developments
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Gastrointestinal Cancer Treatment Product
Table 79. GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 80. GlaxoSmithKline Recent Developments
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Gastrointestinal Cancer Treatment Product
Table 84. Merck Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 85. Merck Recent Developments
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Gastrointestinal Cancer Treatment Product
Table 89. Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 90. Novartis AG Recent Developments
Table 91. Otsuka Holdings Company Details
Table 92. Otsuka Holdings Business Overview
Table 93. Otsuka Holdings Gastrointestinal Cancer Treatment Product
Table 94. Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 95. Otsuka Holdings Recent Developments
Table 96. Stryker Corporation Company Details
Table 97. Stryker Corporation Business Overview
Table 98. Stryker Corporation Gastrointestinal Cancer Treatment Product
Table 99. Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 100. Stryker Corporation Recent Developments
Table 101. Boston Scientific Corporation Company Details
Table 102. Boston Scientific Corporation Business Overview
Table 103. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product
Table 104. Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 105. Boston Scientific Corporation Recent Developments
Table 106. Johnson and Johnson Company Details
Table 107. Johnson and Johnson Business Overview
Table 108. Johnson and Johnson Gastrointestinal Cancer Treatment Product
Table 109. Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 110. Johnson and Johnson Recent Developments
Table 111. CONMED Corporation Company Details
Table 112. CONMED Corporation Business Overview
Table 113. CONMED Corporation Gastrointestinal Cancer Treatment Product
Table 114. CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 115. CONMED Corporation Recent Developments
Table 116. Bristol-Myers Squibb Company Details
Table 117. Bristol-Myers Squibb Business Overview
Table 118. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product
Table 119. Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 120. Bristol-Myers Squibb Recent Developments
Table 121. Pfizer Company Details
Table 122. Pfizer Business Overview
Table 123. Pfizer Gastrointestinal Cancer Treatment Product
Table 124. Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 125. Pfizer Recent Developments
Table 126. Celltrion Inc Company Details
Table 127. Celltrion Inc Business Overview
Table 128. Celltrion Inc Gastrointestinal Cancer Treatment Product
Table 129. Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 130. Celltrion Inc Recent Developments
Table 131. Amgen Limited Company Details
Table 132. Amgen Limited Business Overview
Table 133. Amgen Limited Gastrointestinal Cancer Treatment Product
Table 134. Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 135. Amgen Limited Recent Developments
Table 136. Celgene Corporation Company Details
Table 137. Celgene Corporation Business Overview
Table 138. Celgene Corporation Gastrointestinal Cancer Treatment Product
Table 139. Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 140. Celgene Corporation Recent Developments
Table 141. Sanofi Company Details
Table 142. Sanofi Business Overview
Table 143. Sanofi Gastrointestinal Cancer Treatment Product
Table 144. Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 145. Sanofi Recent Developments
Table 146. Mylan N.V. Company Details
Table 147. Mylan N.V. Business Overview
Table 148. Mylan N.V. Gastrointestinal Cancer Treatment Product
Table 149. Mylan N.V. Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 150. Mylan N.V. Recent Developments
Table 151. Samsung Bioepis Company Details
Table 152. Samsung Bioepis Business Overview
Table 153. Samsung Bioepis Gastrointestinal Cancer Treatment Product
Table 154. Samsung Bioepis Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 155. Samsung Bioepis Recent Developments
Table 156. Teva Pharmaceutical Industries Ltd. Company Details
Table 157. Teva Pharmaceutical Industries Ltd. Business Overview
Table 158. Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Product
Table 159. Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Cancer Treatment Business (2018-2023) & (US$ Million)
Table 160. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Gastrointestinal Cancer Treatment Market Share by Type: 2022 VS 2033
Figure 3. Surgery Features
Figure 4. Targeted Drugs Therapy Features
Figure 5. Chemo Therapy Features
Figure 6. Adjuvant Chemotherapy Features
Figure 7. Radiation Therapy Features
Figure 8. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Gastrointestinal Cancer Treatment Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Research Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Gastrointestinal Cancer Treatment Report Years Considered
Figure 15. Global Gastrointestinal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Gastrointestinal Cancer Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Gastrointestinal Cancer Treatment Market Share by Region: 2022 VS 2033
Figure 18. Global Gastrointestinal Cancer Treatment Market Share by Players in 2022
Figure 19. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Gastrointestinal Cancer Treatment Revenue in 2022
Figure 21. North America Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
Figure 23. North America Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
Figure 24. North America Gastrointestinal Cancer Treatment Market Share by Country (2018-2033)
Figure 25. United States Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Gastrointestinal Cancer Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
Figure 29. Europe Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
Figure 30. Europe Gastrointestinal Cancer Treatment Market Share by Country (2018-2033)
Figure 31. Germany Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Gastrointestinal Cancer Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
Figure 39. China Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
Figure 40. Asia Gastrointestinal Cancer Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
Figure 42. Asia Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
Figure 43. Asia Gastrointestinal Cancer Treatment Market Share by Region (2018-2033)
Figure 44. Japan Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Gastrointestinal Cancer Treatment Market Share by Country (2018-2033)
Figure 54. Brazil Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Gastrointestinal Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Eli Lilly Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 61. F. Hoffmann Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 63. Merck Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 64. Novartis AG Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 65. Otsuka Holdings Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 66. Stryker Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 67. Boston Scientific Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 68. Johnson and Johnson Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 69. CONMED Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 71. Pfizer Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 72. Celltrion Inc Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 73. Amgen Limited Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 74. Celgene Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 75. Sanofi Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 76. Mylan N.V. Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 77. Samsung Bioepis Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 78. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2018-2023)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries